These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Controversies in hypertension: mild hypertension, isolated systolic hypertension, and the choice of a step one drug. Cressman MD; Gifford RW Clin Cardiol; 1983 Jan; 6(1):1-10. PubMed ID: 6339130 [TBL] [Abstract][Full Text] [Related]
49. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses. Thomopoulos C; Parati G; Zanchetti A J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720 [TBL] [Abstract][Full Text] [Related]
50. Essential hypertension. Messerli FH; Williams B; Ritz E Lancet; 2007 Aug; 370(9587):591-603. PubMed ID: 17707755 [TBL] [Abstract][Full Text] [Related]
51. Current therapy, present limitations and future goals for systemic hypertension. Tarazi RC; Fouad-Tarazi FM Am J Cardiol; 1986 Sep; 58(8):3D-7D. PubMed ID: 3532751 [TBL] [Abstract][Full Text] [Related]
52. Effects of oral antihypertensive agents on blood lipid levels. Leren P Clin Ther; 1986; 8(3):309-19. PubMed ID: 2872961 [TBL] [Abstract][Full Text] [Related]
53. Antihypertensive drugs: an overview. Ram CV Am J Cardiovasc Drugs; 2002; 2(2):77-89. PubMed ID: 14727984 [TBL] [Abstract][Full Text] [Related]
54. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs. Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887 [TBL] [Abstract][Full Text] [Related]
56. Treating the patient with mild hypertension and renal insufficiency. Gunnells JC Am J Cardiol; 1983 Feb; 51(4):651-6. PubMed ID: 6131605 [TBL] [Abstract][Full Text] [Related]
57. Effects of antihypertensive drugs on plasma lipids. Nakamura H Am J Cardiol; 1987 Sep; 60(9):24E-28E. PubMed ID: 3661454 [TBL] [Abstract][Full Text] [Related]
58. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience). Kannel WB Am J Cardiol; 1996 Feb; 77(6):6B-11B. PubMed ID: 8848993 [TBL] [Abstract][Full Text] [Related]
59. Cardiovascular effects of antihypertensive drugs--involvement in the therapeutic choice. Luque-Otero M; Fernandez-Pinilla C Am J Cardiol; 1990 May; 65(17):33H-36H. PubMed ID: 2184651 [TBL] [Abstract][Full Text] [Related]